Moreover, findings from substantial randomized controlled trials (RCTs), such as the COAPT study, suggest a notable trend toward reduced hospitalization due to HF and decreased all-cause mortality among HF patients with moderate to severe secondary MR who undergo mitral valve clip therapy [ 103 ].
← all excerpts
Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction.
1
—
—